We are live on ! Find out more
MCM

Marathon Capital Management Portfolio holdings

AUM $494M
1-Year Est. Return 42.6%
This Fund
S&P 500
This Quarter Est. Return
+11.7%
1 Year Est. Return
+42.6%
3 Year Est. Return
+70.91%
5 Year Est. Return
+55.81%
10 Year Est. Return
+429.8%
AUM
$437M
AUM Growth
+$44.4M
Cap. Flow
+$7.6M
Cap. Flow %
1.74%
Top 10 Hldgs %
39.84%
Holding
178
New
15
Increased
34
Reduced
73
Closed
15

Top Buys

Rank Stock Value
1
BIL icon
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
+$7.74M
2
ADBE icon
Adobe
ADBE
+$4.47M
3
NVO
Novo Nordisk
NVO
+$3.36M
4
ADMA icon
ADMA Biologics
ADMA
+$3.13M
5
PAR icon
PAR Technology
PAR
+$2.96M

Top Sells

Rank Stock Value
1
SYM icon
Symbotic
SYM
+$3.37M
2
TROW icon
T. Rowe Price
TROW
+$2.47M
3
PFE icon
Pfizer
PFE
+$2.04M
4
GLW icon
Corning
GLW
+$1.04M
5
CALX icon
Calix
CALX
+$946K

Sector Composition

Rank Sector Weight
1 Financials 24.76%
2 Technology 21.1%
3 Healthcare 12.26%
4 Industrials 10.95%
5 Energy 7.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CSX icon
101
CSX Corp
CSX
$93.1B
$481K 0.11%
13,548
– –
AVGO icon
102
Broadcom
AVGO
$2.04T
$480K 0.11%
1,455
– –
TMHC
103
DELISTED
Taylor Morrison
TMHC
$462K 0.11%
7,000
– –
GTY
104
Getty Realty Corp
GTY
$2.07B
$438K 0.1%
16,340
+750
+5% +$20.9K
RIO icon
105
Rio Tinto
RIO
$164B
$437K 0.1%
6,615
– –
PFE icon
106
Pfizer
PFE
$153B
$434K 0.1%
17,035
-82,475
-83% -$2.04M
CRBG icon
107
Corebridge Financial
CRBG
$15B
$429K 0.1%
13,385
+600
+5% +$20.5K
SBUX icon
108
Starbucks
SBUX
$120B
$418K 0.1%
4,940
– –
IBB icon
109
iShares Biotechnology ETF
IBB
$9.77B
$406K 0.09%
2,815
-500
-15% -$68.3K
SYK icon
110
Stryker
SYK
$130B
$400K 0.09%
1,081
– –
DUK icon
111
Duke Energy
DUK
$97.3B
$391K 0.09%
3,162
-10
-0.3% -$1.21K
BMY icon
112
Bristol-Myers Squibb
BMY
$132B
$386K 0.09%
8,564
+755
+10% +$35.3K
MXL icon
113
MaxLinear
MXL
$6.8B
$362K 0.08%
22,500
– –
NEM icon
114
Newmont
NEM
$119B
$358K 0.08%
4,242
– –
CIVI
115
DELISTED
Civitas Resources
CIVI
$328K 0.08%
10,100
+1,060
+12% +$33.9K
MPC icon
116
Marathon Petroleum
MPC
$83.7B
$328K 0.08%
1,700
– –
XRAY icon
117
Dentsply Sirona
XRAY
$2.43B
$325K 0.07%
25,575
– –
CNX icon
118
CNX Resources
CNX
$5.2B
$321K 0.07%
10,000
– –
AMGN icon
119
Amgen
AMGN
$222B
$321K 0.07%
1,138
– –
OKE icon
120
Oneok
OKE
$54.5B
$314K 0.07%
4,300
-150
-3% -$11.5K
DIS icon
121
Walt Disney
DIS
$181B
$312K 0.07%
2,728
-310
-10% -$36.5K
ELV icon
122
Elevance Health
ELV
$85.5B
$307K 0.07%
+949
New +$295K
NBR icon
123
Nabors Industries
NBR
$1.21B
$307K 0.07%
7,500
– –
COF icon
124
Capital One
COF
$134B
$300K 0.07%
1,409
– –
SMRI icon
125
Bushido Capital US Equity ETF
SMRI
$662M
$295K 0.07%
8,510
-10
-0.1% -$335
3 4
5
6 7

Similar funds

LI
Lafayette Investments Ashton, Maryland $494M AUM 11.42% 1-Year Est. Return
SAS
Stelac Advisory Services New York $494M AUM 23.25% 1-Year Est. Return
BFIC
Bedell Frazier Investment Counselling Walnut Creek, California $495M AUM 29.32% 1-Year Est. Return
FSA
Financial Sense Advisors San Diego, California $493M AUM 50.68% 1-Year Est. Return
TAM
Talaria Asset Management Melbourne, Australia $495M AUM 21.62% 1-Year Est. Return
TAA
Turiya Advisors Asia Hong Kong $496M AUM 75.42% 1-Year Est. Return
NYLIC
New York Life Insurance Company New York $491M AUM 10.97% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $490M AUM 66.64% 1-Year Est. Return

Marathon Capital Management's Q3 2025 Portfolio in Review

As of Q3 2025, Marathon Capital Management held 178 positions worth $437M, up 11% from $393M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Marathon Capital Management's Q3 2025 filing shows 15 new, 34 increased, 73 reduced and 15 closed positions. Its largest new stake was Adobe: 12,457 shares worth $4.39M. The largest sale was Symbotic, an estimated $3.37M.

By sector, the portfolio is most concentrated in Financials at 25% of assets, down from 27% a quarter earlier, followed by Technology and Healthcare.

  • Marathon Capital Management's largest Q3 2025 buy was Adobe: 12,457 shares worth $4.39M.
  • Marathon Capital Management added most to State Street SPDR Bloomberg 1-3 Month T-Bill ETF in Q3 2025, an estimated $7.74M increase.
  • Marathon Capital Management's biggest Q3 2025 reduction was Symbotic, cutting an estimated $3.37M.
  • Marathon Capital Management fully exited Sarepta Therapeutics in Q3 2025, selling an estimated $711K.
  • Marathon Capital Management's ten largest holdings make up 40% of its $437M portfolio in Q3 2025.
  • Marathon Capital Management opened 15 new positions and closed 15 in Q3 2025.
  • Marathon Capital Management's portfolio value rose 11% quarter-over-quarter to $437M.

Based on Marathon Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.